| P2093 | author name string | Hyun-Soo Kim | |
| | So-Young Joo | |
| | Jong-Sun Rew | |
| | Sung-Bum Cho | |
| | Wan-Sik Lee | |
| | Young-Eun Joo | |
| | Cho-Yun Chung | |
| | Young-Lan Park | |
| | Eun Myung | |
| | Young-A Song | |
| | Kang-Jin Park | |
| | Nack-Sung Kim | |
| P2860 | cites work | Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. | Q37659096 |
| | Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. | Q38518709 |
| | Regulation of lipopolysaccharide-induced inflammatory response by heat shock protein 27 in THP-1 cells | Q39691529 |
| | Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro | Q39775060 |
| | The anti-inflammatory and anti-cancer properties of epigallocatechin-3-gallate are mediated by folate cycle disruption, adenosine release and NF-kappaB suppression. | Q39933343 |
| | Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines | Q40381286 |
| | Effect of various catechins on the IL-12p40 production by murine peritoneal macrophages and a macrophage cell line, J774.1. | Q40520338 |
| | IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines | Q40715411 |
| | The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. | Q40786357 |
| | Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells | Q41074166 |
| | Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. | Q41143793 |
| | Role of cytokines in inflammatory bowel disease | Q43065113 |
| | Epigallocatechin gallate modulates cytokine production by bone marrow-derived dendritic cells stimulated with lipopolysaccharide or muramyldipeptide, or infected with Legionella pneumophila | Q43428738 |
| | In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse | Q44987441 |
| | Reactive oxygen species level defines two functionally distinctive stages of inflammatory dendritic cell development from mouse bone marrow | Q45808389 |
| | Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid | Q46714538 |
| | Health characteristics of the Asian adult population: United States, 2004-2006. | Q46756690 |
| | Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis | Q46893796 |
| | Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. | Q50685974 |
| | Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-kappa B and CREB in mouse skin: role of p38 MAPK. | Q50691013 |
| | Angiogenesis inhibited by drinking tea. | Q55032963 |
| | Inflammation and cancer | Q24649640 |
| | Good cop, bad cop: the different faces of NF-kappaB | Q28291669 |
| | The MAPK signaling cascade | Q28292599 |
| | Inflammation in atherosclerosis | Q29547428 |
| | Unravelling the pathogenesis of inflammatory bowel disease | Q29547551 |
| | Signaling to NF-kappaB | Q29547844 |
| | Microbial influences in inflammatory bowel diseases | Q29614264 |
| | Complementary and alternative medicine use among adults: United States, 2002 | Q29615129 |
| | Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B | Q29618096 |
| | The key role of macrophages in the immunopathogenesis of inflammatory bowel disease | Q33853551 |
| | Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. | Q33870182 |
| | LPS induction of gene expression in human monocytes | Q34189313 |
| | Multitargeted therapy of cancer by green tea polyphenols | Q34374910 |
| | Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). | Q34478999 |
| | Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide | Q35467694 |
| | Tea polyphenols for health promotion | Q35562949 |
| | The fundamental basis of inflammatory bowel disease | Q35649436 |
| | Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules | Q35679842 |
| | Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse | Q36364924 |
| | Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. | Q36410856 |
| | NF-kappaB and the intestine: friend or foe? | Q36925725 |
| | Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. | Q36943726 |
| | Tea polyphenols, their biological effects and potential molecular targets | Q37070437 |
| | Cellular signaling perturbation by natural products | Q37373545 |
| P433 | issue | 2 | |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 188-196 | |
| P577 | publication date | 2012-04-17 | |
| P1433 | published in | Gut and liver | Q26841957 |
| P1476 | title | Epigallocatechin-3-gallate Inhibits LPS-Induced NF-κB and MAPK Signaling Pathways in Bone Marrow-Derived Macrophages | |
| P478 | volume | 6 | |